Skip Main Navigation
Page Content

Save This Event

Event Saved

Bear Creek Capital presents Hemispherx Biopharma, Inc. (HEB)-Dinner

Raymond Oliver

Wednesday, December 13, 2017 at 5:30 PM (EST)

Bear Creek Capital presents Hemispherx Biopharma, Inc....

Registration Information

Type End Quantity
HEB Attending Dinner Guest-December 13, 2017 7h 17m Free  

Share Bear Creek Capital presents Hemispherx Biopharma, Inc. (HEB)-Dinner

Event Details

YOU ARE CORDIALLY INVITEDBear Creek Capital

HOSTS

Dinner & Corporate Presentation

 

Who:     Hemispherx Biopharma, Inc. (NYSE MRKT:  HEB)

When:   Wednesday, December 13, 2017

Where:  Ruth's Chris Steak House

              610 N. Orlando Avenue

              Winter Park, FL 32789

Time:    Promptly at 5:30 PM


We hope to see you there!

Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders.

Hemispherx’s flagship products include Alferon N Injection® and the experimental therapeutics Ampligen®.  Ampligen® is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including Chronic Fatigue Syndrome.  Hemispherx’s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. Because Ampligen® is experimental in nature, they are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials.

The FDA approval of Alferon N Injection® is limited to the treatment of refractory or recurrent external genital warts in patients 18 years of age or older.  The Company’s Alferon® N approval in Argentina includes the use of Alferon N Injection® (under the brand name “Naturaferon”) for use in any patients who fail, or become intolerant to recombinant interferon, including patients with chronic active hepatitis C infection.

The Company wholly owns and exclusively operates a GMP certified manufacturing facility in the United States for commercial products.

In the News

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017

Hemispherx Human Safety Study of Intranasal Ampligen® with Influenza Vaccine Shows Ampligen was Generally Well-Tolerated

Hemispherx Biopharma Announces Collaboration with Millions Missing Canada to Bring Medication to Canadians for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Hemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue Syndrome

Hemispherx Updates Status of Immuno-Oncology Program in Pancreatic Cancer




Presentation Format: 

5:30 p.m. to 6:00 p.m. – Cocktails & Networking

6:00 p.m. to 7:30 p.m. – Dinner & Presentation

 

Contact:

Raymond Oliver

CEO, Bear Creek Capital

321-439-2120

roliver@bearcreekcap.com

Created by

Parallel Marketing Services

Have questions about Bear Creek Capital presents Hemispherx Biopharma, Inc. (HEB)-Dinner? Contact Raymond Oliver

Save This Event

Event Saved

When & Where


Ruth's Chris Steak House
610 N. Orlando Avenue
Winter Park, FL 32789

Wednesday, December 13, 2017 at 5:30 PM (EST)


  Add to my calendar
Bear Creek Capital presents Hemispherx Biopharma, Inc. (HEB)-Dinner
Things to do in Winter Park, FL Networking Business

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.